- +522.9% price growth over the last year
- Beat earnings estimates in 3 of the last 4 quarters
- +219.6% YTD performance
Evaluation of Spyre Therapeutics, Inc. stock downgraded after the last trading session
(Updated on Jul 10, 2026)
The Spyre Therapeutics, Inc. stock price fell by -1.02% on the last day (Friday, 10th Jul 2026) from $98.75 to $97.74. During the last trading day the stock fluctuated 5.08% from a day low at $94.13 to a day high of $98.92. The price has risen in 6 of the last 10 days and is up by 10.23% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -540 thousand shares and in total, 776 thousand shares were bought and sold for approximately $75.82 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 33.22% during the next 3 months and, with a 90% probability hold a price between $107.14 and $141.15 at the end of this 3-month period.
SYRE Signals & Forecast
The Spyre Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $92.91 and $82.71. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -2.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Spyre Therapeutics, Inc. stock
Spyre Therapeutics, Inc. finds support from accumulated volume at $97.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $4.79 between high and low, or 5.08%. For the last week, the stock has had daily average volatility of 5.91%.
Our recommended stop-loss: $93.67 (-4.16%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 13 days ago.)
Trading Expectations (SYRE) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect Spyre Therapeutics, Inc. to open at $96.93, and during the day (based on 14 day Average True Range), to move between $95.07 and $100.41, which gives a possible trading interval of +/-$5.33 (+/-5.61%) up or down from last closing price. If Spyre Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.61% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $97.05 (0.71%) than the resistance at $98.75 (1.03%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Spyre Therapeutics, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Spyre Therapeutics, Inc. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score:
2.558
Buy Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 13, 2026 - $96.93 ( 0.83%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
SYRE Performance
Trading levels for SYRE
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 101.72 | 4.07% |
| R2 | 99.89 | 2.20% |
| R1 | 98.76 | 1.04% |
| Price | 97.74 | |
| S1 | 95.10 | -2.70% |
| S2 | 93.97 | -3.85% |
| S3 | 92.15 | -5.72% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 100.32 | 2.64% |
| R1 | 98.75 | 1.03% |
| Price | 97.74 | |
| S1 | 97.05 | -0.706% |
| S2 | 87.89 | -10.08% |
| S3 | 86.24 | -11.77% |
FAQ
Click here for our free guide on how to buy Spyre Therapeutics, Inc. Stock.
Buy SYRE